56 related articles for article (PubMed ID: 1378245)
1. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
Nielsen JB; Bertelsen A; Lou HC
Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
[TBL] [Abstract][Full Text] [Related]
2. CSF and urine biogenic amine metabolites in Rett syndrome.
Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B
Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
Langlais PJ; Walsh FX; Bird ED; Levy HL
Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
[TBL] [Abstract][Full Text] [Related]
7. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
9. [Usual values for 5-hydroxy-indol acetic acid and homovanillic acid in cerebrospinal fluid].
Dhondt JL; Forzy G
Ann Biol Clin (Paris); 2003; 61(1):69-75. PubMed ID: 12604388
[TBL] [Abstract][Full Text] [Related]
10. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
Pranzatelli MR; Huang YY; Tate E; Goldstein DS; Holmes CS; Goldstein EM; Ketner K; Kinast M; Lange BM; Sanz A; Shevell MI; Stanford RE; Taff IP
Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
[TBL] [Abstract][Full Text] [Related]
11. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome.
Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK
Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
[TBL] [Abstract][Full Text] [Related]
13. [Metabolites of neurotransmitters in the cerebrospinal fluid in children].
Zeman J; Böswart J
Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome.
Nielsen JB; Lou HC; Andresen J
Brain Dev; 1990; 12(1):143-7. PubMed ID: 1693042
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
16. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
17. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
18. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
Nishijima K; Ishiguro T
Seishin Shinkeigaku Zasshi; 1989; 91(6):429-56. PubMed ID: 2479043
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome.
Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV
Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624
[TBL] [Abstract][Full Text] [Related]
20. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
Takano K; Ishiguro T
Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
